Senti Biosciences, INC. (SNTI) — 10-Q Filings

10-Q Filings (6)

• Senti Biosciences' Cash Dwindles Amid Rising R&D, Going Concern Looms — Nov 13, 2025 Risk: high
  Senti Biosciences, Inc. (SNTI) reported a net loss of $46.97 million for the nine months ended September 30, 2025, a 10% improvement from the $52.18 million net
• Senti Biosciences Remains Pre-Revenue, Focuses on GeneFab Development — Aug 7, 2025 Risk: high
  Senti Biosciences, Inc. (SNTI) reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods, indicating its pre-
• Senti Biosciences Files Q1 2025 10-Q — May 6, 2025 Risk: medium
  Senti Biosciences, Inc. filed its quarterly report for the period ending March 31, 2025. The company, previously known as Dynamics Special Purpose Corp., is foc
• Senti Biosciences Files Q3 2024 10-Q — Nov 14, 2024 Risk: medium
  Senti Biosciences, Inc. filed its 10-Q for the period ending September 30, 2024. The company, focused on biological products, reported its financial status and
• Senti Biosciences Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  Senti Biosciences, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business acti
• Senti Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: low
  Senti Biosciences, Inc. (SNTI) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Senti Biosciences, Inc. filed a 10-Q report for the period ending Ma

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX